Indoco Remedies Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹467.50 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 1.71 per cent from ₹475.61 crore. This corresponds to a year-on-year *(YoY) growth of 6.33 per cent.
Operating Profit
Operating Profit stands at ₹41.02 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 17.48 per cent from ₹49.71 crore. This corresponds to a year-on-year *(YoY) growth of 134.00 per cent.
PBDT
PBDT stands at ₹112.25 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1,398.66 per cent from ₹7.49 crore. This corresponds to a year-on-year *(YoY) growth of 1,712.79 per cent.
Profit Before Tax
Profit Before Tax stands at ₹77.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 410.88 per cent from ₹-25.00 crore. This corresponds to a year-on-year *(YoY) growth of 312.00 per cent.
Net Profit
Net Profit stands at ₹65.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 376.35 per cent from ₹-23.68 crore. This represents a 280.03 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Indoco Remedies Ltd Earnings
- YOY
- QOQ
Indoco Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Indoco Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Indoco Remedies Ltd Financial Reports
Indoco Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Indoco Remedies | 2.16% | -2.09% | -4.17% | -6.88% | 6.52% | -19.12% |
| Panacea Biotec | 3.87% | 5.42% | -3.71% | -32.65% | 4.56% | -19.79% |
| Sai Parenteral's | 0.31% | -0.08% | -1.28% | -11.37% | 14.25% | 23.01% |
| Syncom Formul. | 2.60% | -3.05% | 23.30% | 65.29% | 65.65% | 40.07% |
| Venus Remedies | 0.70% | -4.84% | 2.85% | -15.60% | 49.50% | 246.08% |
| Windlas Biotech | -1.25% | -6.79% | -15.74% | 10.16% | 6.82% | 1.32% |
| Hester Bios | 0.99% | 4.66% | -0.82% | -10.78% | 49.18% | 24.72% |
Company Info
Company Information
Chairman & Non Executive Dir. : Suresh G Kare
ED / MD / Promoter : Aditi Kare Panandikar
Joint MD & Executive Director : Sundeep V Bambolkar
Independent Non Exe. Director : Satish Shenoy
Independent Non Exe. Director : Ajay Mulgaokar
Independent Non Exe. Director : Vasudha V Kamat
Independent Non Exe. Director : Abhijit Y Gore
CS / Compliance Officer / Legal Head : RAMANATHAN HARIHARAN